Financial Assistance
and Savings Options
for JAKAFI® (ruxolitinib) and JAKAFI XR™ (ruxolitinib)
Healthcare Professionals
Enroll a Patient
For Eligible Patients With Commercial Prescription Insurance
IncyteCARES Savings Program
IncyteCARES Savings Program
Eligible patients can receive JAKAFI or JAKAFI XR for as little as $0, subject to certain limits*
To qualify, patients must:
- Have commercial prescription drug coverage. Patients insured under federal or state government prescription drug programs—including Medicare Part B or D, Medicare Advantage, Medicaid, or TRICARE—are not eligible. Patients without prescription drug coverage are also not eligible
- Be a resident of the United States or Puerto Rico
- Have a valid prescription for JAKAFI or JAKAFI XR for an FDA-approved use
*Uninsured, cash-paying, or Alternate Funding Program (AFP) patients are not eligible. Not valid for patients insured through Medicare Part D, Medicare Advantage, Medicaid, TRICARE, or any state medical or pharmaceutical assistance program. Patient enrollment in a copay adjustment program, such as a maximizer or accumulator program, may impact the value of this offer. Annual benefit maximum applies, as may other restrictions. Valid prescription for JAKAFI® (ruxolitinib) or JAKAFI XR™ (ruxolitinib) extended-release tablets for an FDA-approved indication or compendia-recognized use is required. Please see the full Patient Terms and Conditions or call IncyteCARES at 1-855-452-5234. Update effective as of April 1, 2026.
*Uninsured, cash-paying, or Alternate Funding Program (AFP) patients are not eligible. Not valid for patients insured through Medicare Part D, Medicare Advantage, Medicaid, TRICARE, or any state medical or pharmaceutical assistance program. Patient enrollment in a copay adjustment program, such as a maximizer or accumulator program, may impact the value of this offer. Annual benefit maximum applies, as may other restrictions. Valid prescription for JAKAFI® (ruxolitinib) or JAKAFI XR™ (ruxolitinib) extended-release tablets for an FDA-approved indication or compendia-recognized use is required. Please see the full Patient Terms and Conditions or call IncyteCARES at 1-855-452-5234. Update effective as of April 1, 2026.
How to enroll your patients:
Option 1: Enroll your patient in IncyteCARES.
We’ll do the rest. As part of our introductory call, we inform all newly enrolled patients about the IncyteCARES Savings Program and help eligible patients apply for it.
Option 2: Complete an application at IncyteCARESsavings.Jakafi.com.
Once you submit the application, a patient membership number is immediately issued and ready to use. We will send the patient a welcome letter that shows their membership number. Your patient does not need to enroll in IncyteCARES to be eligible for the Savings Program.
For more information, call IncyteCARES at 1-855-452-5234, Monday through Friday, 8 AM–8 PM ET.
For Eligible Patients Who Are Uninsured or Underinsured
IncyteCARES Patient Assistance Program
IncyteCARES Patient Assistance Program
Eligible patients can receive JAKAFI or JAKAFI XR free of charge†
The IncyteCARES Patient Assistance Program (PAP) helps eligible patients who do not have prescription drug insurance or who have trouble affording their out-of-pocket costs. No purchase contingencies or other obligations apply.
To qualify, patients must:
- Be confirmed as eligible for and enrolled in IncyteCARES
- Be a resident of the United States or Puerto Rico
- Have a valid prescription for JAKAFI or JAKAFI XR for an FDA-approved use
- Meet one of these 3 criteria:
Uninsured
- Have no prescription drug coverage and meet household income criteria
Underinsured‡
- Have Medicare Part B, Medicare Part D, or Medicare Advantage and meet household income criteria
- Have Medicare Part B, Medicare Part D, or Medicare Advantage and meet household income criteria
- Have any other type of prescription drug insurance (commercial, Medicaid, etc) but have exhausted or been denied coverage for JAKAFI or JAKAFI XR and meet household income criteria
How to enroll your patients:
First, you must enroll your patient in IncyteCARES.
You can provide their required income information on the IncyteCARES enrollment form to start the process. Or we can explain the program and gather their income information during the introductory call we make to all patients newly enrolled in IncyteCARES.
Within 3 business days, patients are notified of "conditional approval," which allows them to receive free medication for 90 days. Full approval is only granted once income information is submitted and confirmed.
†Terms and conditions apply. Terms of this program may change at any time.
‡Patients who are enrolled in an Alternate Funding Program (AFP) are not eligible to receive free drug.
For Patients Whose Insurance Coverage Approval Is Delayed
IncyteCARES Temporary Patient Assistance Program
IncyteCARES Temporary Patient Assistance Program
Eligible patients may be able to receive a free short-term supply of JAKAFI or JAKAFI XR§
If a patient’s prescription drug insurer requires more than a 3-day wait for determining coverage approval, we may be able to provide a free temporary supply of the prescribed Incyte medication in the meantime. Free product is offered to eligible patients without any purchase contingency or other obligation.
To qualify, patients must:
- Be confirmed as eligible for and enrolled in IncyteCARES
- Have commercial prescription drug coverage or a healthcare exchange plan. Patients insured under federal or state government prescription drug programs—including Medicare Part D, Medicare Advantage, Medicaid, or TRICARE—are not eligible. Patients without prescription drug coverage are also not eligible
- Be a resident of the United States or Puerto Rico
- Have a valid prescription for JAKAFI or JAKAFI XR for an FDA-approved use
- Submit a proof of insurance claim verifying the delay. This may be a notice you or your patient receive from the insurance company
To learn more:
Call IncyteCARES at 1-855-452-5234, Monday through Friday, 8 AM–8 PM ET.
For Patients Covered by Any Type of Insurance or Without Insurance
Information About Nonprofit or Other Support Organizations
Information About Nonprofit or Other Support Organizations
Patients may be eligible for help with medication, treatment-related travel, and other costs
If your patients do not qualify for our IncyteCARES Savings Program or Patient Assistance Program, we may be able to provide information about other organizations or independent foundations that offer support. If eligible, these independent organizations sometimes provide help with medicine costs, transportation or lodging expenses related to treatment, or counseling services offered at reduced or no cost. Eligibility and availability of these assistance programs are determined by the individual organizations.
To learn more:
Call IncyteCARES at 1-855-452-5234, Monday through Friday, 8 AM–8 PM ET.
